|
|
|
|
 |
|
Lunchtime
Activities & Evening Symposia |
Tuesday| April
27, 2010 |
Evening Satellite
Symposia
7:00 PM-8:30 PM |
#1. Antiplatelet
Options: The Changing Landscape
Main Arena, Vista Hall, Level B2
Co-sponsored by AstraZeneca Co., Ltd., Daiichi-Sankyo
Korea & Lilly Korea, and Korea Otsuka Pharmaceutical Co.,
Ltd. |
Moderators: David E.
Kandzari, Seung-Jung Park |
Panelists:
David J. Cohen, Duk-Woo Park, Matthew Price |
7:00 PM |
Clopidogrel: Current OASIS7 - Double
Is Better !!  |
David J. Cohen |
7:15 PM |
Prasugrel: TRITON - Evolution Begins
Here !!  |
David E. Kandzari |
7:30 PM |
Ticagrelor: PLATO - A New Chapters
Opens
| Matthew Price |
7:45 PM |
Alternative and Next Antiplatelet
Therapy Beyond ADP Blocker
| Duk-Woo Park |
8:00 PM
|
Panel Discussion |
|
8:30 PM |
Adjourn |
|
|
|
|
#2. Alumni
Night for ACT Attendees
Room 1-1, Level 1
Organized by CVRF |
Moderators: Cheol Whan
Lee, Seung-Jung Park |
Panelists:
Soo-Jin Kang, Won-Jang Kim, Young-Hak Kim, Jong-Young Lee, Seung-Whan
Lee, Duk-Woo Park |
6:00 PM |
Dinner |
|
|
|
|
7:00 PM |
Welcome Address |
Cheol Whan Lee |
|
|
|
|
Meet Our Experts: Healthy Opinions, Smart Decisions
"Case Presentation" |
7:05 PM
|
PCI to LMS on My Youngest Female Patient |
Yoon-Sin Chong |
7:20 PM
|
Retrograde PCI via Transradial Approach
with Single Catheter |
Wataru Nagamatsu |
7:35 PM
|
Percutaneous Treatment for Massive
Intracoronary Thrombus (Using PIT Catheter) |
Takuma Sato |
7:50 PM
|
Panel Discussion |
|
|
|
|
|
Featured Lecture |
8:00 PM |
Therapy in Evolution: Percutaneous Aortic Valve Replacement  |
Martin B. Leon |
|
|
|
8:20 PM |
Closing Remark |
|
8:30 PM |
Adjourn |
|
|
Wednesday| April
28, 2010 |
Lunchtime Activities
12:40 PM-1:40 PM |
#1.
DES in 2010: Lessons Learned
Coronary Arena, Level 1
Co-sponsored by Medtronic Co, Ltd. |
Moderator: Martin B.
Leon |
Panelists:
Shirish Hiremath, Yangsoo Jang, Hyo-Soo Kim, Shu Kin Li, Philip
Wong, Hongbing Yan, Wei-Hsian Yin |
12:40 PM |
Welcome Address |
|
12:45 PM |
Early DES - What Did We Learn - Updates
from the ZEST Trial  |
Duk-Woo Park |
1:00 PM |
Relevant Clinical Trials Designs:
Balancing Regulatory and Medical Evidence Needs  |
Ian T. Meredith |
1:15 PM |
DES of the Future: Design Goals and
Challenges  |
Martin B. Leon |
1:30 PM
|
Discussion, Q & A |
|
1:40 PM |
Adjourn |
|
#2.
New Perspective on Cardiovascular Disease
Endovascular Arena, Level 1
Organized by CVRF |
Moderator: Dong Joo
Oh |
12:40 PM |
Opening Address |
Dong Joo Oh |
12:45 PM |
Optimal Dosing of Antiplatelet Therapy
in Patients With ACS Undergoing an Early Invasive Strategy:
Insight from CURRENT-OASIS7 Trial  |
David J. Cohen |
1:05 PM |
Antiplatelet Therapy in AF  |
Sun Uck Kwon |
1:25 PM
|
Discussion, Q & A |
|
1:40 PM |
Adjourn |
|
|
|
|
#3.
For the At-Risk Acute Coronary Syndrome Patient: The Role
of Glycoprotein IIb/IIIa Inhibitor
Room 1-1(Calla Room), Level 1
Co-sponsored by Handok Pharmaceuticals Co., Ltd |
Moderator: Taehoon Ahn |
12:40 PM |
Welcome Address |
Taehoon Ahn |
12:45 PM |
The Optimal Medical Treatment Choice
for ACS Patients |
Marco Valgimigli |
1:15 PM
|
Guidelines and Current Practice in
the Management of ACS Patients  |
Young-Hak Kim |
1:30 PM
|
Q & A |
|
1:40 PM |
Adjourn |
|
|
|
|
#4.
DES Summit
"Futuristic Technology: New DES"
Room 2-1(Presidio 1 & 2), Level 2
Organized by CVRF |
Moderators: Adnan Kastrati,
Gregg W. Stone |
Panelists:
Eberhard Grube, Kiyotaka Iwasaki, Ron Waksman |
12:40 PM |
Systemic Review of Longterm Outcomes
after First- vs. Second-Generation DES  |
Adnan Kastrati |
12:55 PM |
Bioabsorble or Free-Polymer DES: Current
and New Technologies  |
Gregg W. Stone |
1:10 PM |
Nanoparticle or Nanomatrix Technologies
for DES  |
Ron Waksman |
1:25 PM |
Panel Discussion |
|
1:40 PM |
Adjourn |
|
|
|
|
#5.
Recapturing the Magic with Atorvastatin!: ACS patients before
and after PCI
Room 3-1(Cosmos Room), Level 3
Hosted by Pfizer Pharmaceutical Korea Ltd. |
Moderator: Seong-Wook
Park |
Panelists:
Young-Keun Ahn, Seung-Ho Hur, Han Cheol Lee |
12:40 PM |
Welcome Address |
|
12:40 PM |
Latest Update on Upstream Atorvastatin
Therapy  |
In-Ho Chae |
1:20 PM
|
Panel Discussion |
|
2:00 PM |
Adjourn |
|
|
|
|
#6.
Next Generation DES: Today and Tomorrow
Tutorial Arena, Level 4
Organized by CVRF, Supported by Educational Grant from
Abbott Vascular
|
Moderators: Seung-Jung
Park, Chuck Simonton |
Panelists:
Myeong-Chan Cho, Donghoon Choi, Myung-Ho Jeong, Young Jo Kim,
Do Sun Lim, Junghan Yoon |
12:40 PM |
Welcome Address |
|
12:45 PM |
COMPARE Study Update  |
Elvin Kedhi |
1:00 PM |
Xience V in Real Life  |
Seung-Jung Park |
1:15 PM |
Xience Prime & Fully Bioabsorbable
Stent Technology  |
Chuck Simonton |
1:30 PM
|
Q & A |
|
1:40 PM
|
Adjourn |
|
|
|
|
Evening Satellite
Symposia
6:30 PM-8:35 PM |
#3. DES -
From Complex to the Future
Coronary Arena, Level 1
Co-sponsored by Johnson & Johnson Medical Korea
|
Moderators: Seung-Jung
Park, Christian M. Spaulding |
Panelists:
Hyeon-Cheol Gwon, Kyoo-Rok Han, Naoto Inoue, Myung-Ho Jeong,
Chong-Jin Kim, Takeshi Kimura, Ki Bae Seung, Junghan Yoon |
6:30 PM |
Opening Address |
Seung-Jung Park |
6:35 PM |
Which Stent in Difficult Lesions?  |
Christian M. Spaulding |
6:55 PM |
Panel Discussion |
|
7:05 PM |
Duration of Dual Antiplatelet Therapy
in DES  |
Seung-Jung Park |
7:25 PM |
Panel Discussion |
|
7:35 PM |
J-Cypher Long-term F/U for Complex
Lesion  |
Takeshi Kimura |
7:55 PM |
Panel Discussion |
|
8:05 PM |
First Clinical Results and Future
Developments of RES Technology 1: NEVO RES Trial  |
Christian M. Spaulding |
8:25 PM |
Panel Discussion |
|
8:35 PM |
Adjourn |
|
|
|
|
#4. A New
Era of Treating CAD without Polymer
Drug-Eluting Balloon - How? Where? Why?
Endovascular Arena, Level 1
Co-sponsored by B.Braun Korea |
Moderator: Seong- Wook
Park |
Panelists:
Taehoon Ahn, In-Ho Chae, Bashir Hanif, Sung-Ho Her, Rohit Khurana,
Moo Hyun Kim, Muhammad Munawar, Jack Wei Chieh Tan |
6:00 PM |
Dinner |
|
6:10 PM |
Welcome Address |
Seong-Wook Park |
6:15 PM |
Key Specifications & Application
of DEB |
Hyo-Soo Kim |
6:45 PM |
PEPCAD IV - Clinical Usage Feedback
& Outlook |
Rosli Mohd Ali |
7:15 PM |
Case Report l - DES-ISR  |
Byoung-Joo Choi |
7:30 PM |
Case Report ll - SVD  |
Hun-Jun Park |
7:45 PM |
Case Report lll - CTO  |
Sajid Dhakam |
8:00 PM |
Panel Discussion |
|
8:30 PM |
Adjourn |
|
|
|
|
|
Thursday| April
29, 2010 |
Lunchtime Activities
12:40 PM-1:40 PM |
#7.
PtCr ELEMENT, Next Generation Beyond Cobalt Chromium
Coronary Arena, Level 1
Co-sponsored by Boston Scientific Korea |
Moderators: Keith D.
Dawkins, Renu Virmani |
Panelists:
Ian T. Meredith, Rosil Mohd Ali |
12:40 PM |
Welcome Address |
Renu Virmani |
12:45 PM |
Feature of PtCr ELEMENT, Next Generation
Beyond CoCr  |
Keith D. Dawkins |
1:00 PM |
Pre Clinical Data and Histological
Finding of PtCr ELEMENT |
Renu Virmani |
1:15 PM
|
PtCr ELEMENT Clinical
Programs: PERSEUS & PLATINUM Clinical Data  |
Ian T. Meredith |
1:30 PM |
Discussion |
|
1:40 PM |
Closing Remark |
Keith D. Dawkins |
|
|
|
#8.
Clinical Impact of the Pro-Healing Stent
Endovascular Arena, Level 1
Co-sponsored by OrbusNeich Medical Korea |
Moderators: Seung-Jung
Park, Harry Suryapranata |
12:40 PM |
Opening Address |
Seung-Jung Park |
12:45 PM |
Can a Pro-Healing Stent Make a Difference?
Final 12-Month Outcomes from the e-HEALING 5,000 Patient Registry
Using the EPC-Coated Genous Stent  |
Kui-Hian Sim |
1:00 PM |
A High Risk Patients' Cohort, Age
over 70 and 80 Years in the Worldwide eHEALING Registry  |
Andres Iniguez |
1:15 PM
|
The Journey for an Ideal Stent: A
20-Year Zwolle Experience in AMI Intervention |
Harry Suryapranata |
1:30 PM |
Q & A followed by Closing Remarks
|
Seung-Jung Park |
1:40 PM |
Adjourn |
|
|
|
|
#9.
Unmet Clinical Need in Post-PCI Platelet Management and Future
Room 1-1(Calla Room), Level 1
Organized by CVRF and Supported Through an Unlimited Educational
Grant from Daiichi-Sankyo Korea & Lilly Korea |
Moderators: David E.
Kandzari, Moo Hyun Kim |
Panelists:
David J. Cohen, Young-Hoon Jeong, Seung-Whan Lee, Duk-Woo Park,
Kyung Woo Park |
12:40 PM |
Welcome Address |
|
12:45 PM |
Unmet Needs in the Current Post PCI
Anti-Platelet Therapy - How Can It Be Overcome? |
David E. Kandzari |
1:05 PM |
Cost-Effectiveness of Prasugrel vs.
Clopidogrel in ACS  |
David J. Cohen |
1:25 PM |
Q & A |
|
1:40 PM |
Adjourn |
|
|
|
|
#10.
Nobori, Clinical Data Up-Date
Room 2-1(Presidio 1 & 2), Level 2
Co-sponsored by Terumo Korea Corporation |
Moderator: Young-Hak
Kim |
12:40 PM |
Welcome Address |
Young-Hak Kim |
12:45 PM |
NOBORI 1 Data Up-Date  |
Bernard Chevalier |
1:00 PM |
NOBORI 2 Latest Findings  |
Gian Battista Danzi |
1:15 PM |
NOBORI Japan Trial Up-Date  |
Yuji Ikari |
1:30 PM |
Q & A |
|
1:40 PM |
Adjourn |
|
|
|
|
#11.
Improving Long Term Patient Outcomes with Biolimus A9TM /
Biodegradable Polymer Technology
Room 3-1(Cosmos Room), Level 3
Co-sponsored by DIO Corp. / Biosensors |
Moderators: Eberhard
Grube, Junghan Yoon |
Panelists:
Yoon Sin Chong, Bum-Kee Hong, Bon-Kwon Koo, Seung-Woon Rha,
Il Rhee |
12:40 PM |
Welcome Address |
Junghan Yoon |
12:45 PM |
LEADERS Clinical Results, Insights
into Complex Patient Population and OCT Findings  |
Antonio Colombo |
1:00 PM |
Asia Pacific BioMatrixTM Experience: BEACON
II – Follow-up and Single Center Experience in Indonesia |
Teguh Santoso |
1:15 PM |
Panel Discussion |
|
1:30 PM |
Take Home Message |
Eberhard Grube |
1:40 PM |
Adjourn |
|
|
|
|
#12.
Advancement of Endovascular Therapy
Tutorial Arena, Level 4
Co-sponsored by Johnson & Johnson Medical Korea Ltd. |
Moderator: Seong-Wook
Park |
12:40 PM |
Welcome Address |
Seong-Wook Park |
12:45 PM |
Future of BTK/CLI treatment  |
Dierk Scheinert |
1:00 PM |
New Devices in CTO treatment - Clinical
Outcome Comparison  |
Dierk Scheinert |
1:15 PM |
Why CAS?  |
William A. Gray |
1:35 PM |
Closing Remark |
Seong-Wook Park |
1:40 PM |
Adjourn |
|
|
|
|
#13.
Evolving Treatment Guideline for Residucal Cardiometabolic
Risk Management
Room 4-1, Level 4
Co-sponsored by MSD Korea |
Moderators: Jae-Joong
Kim, Ki-Bae Seung |
Panelists:
Jang-Ho Bae, Donghoon Choi |
12:40 PM |
Welcome Address |
|
12:45 PM |
Scientific Interpretation of ACCORD-
LIPID  |
Ki Hoon Han |
1:05 PM |
New Treatment Strategy for Heart Failure  |
Suk-Min Kang |
1:25 PM |
Panel Discussion |
|
1:40 PM |
Adjourn |
|
|
|
|
Evening Satellite
Symposia
6:00 PM-9:00 PM |
#5. Atherosclerosis
"From Basic to Translational Research"
Coronary Arena, Level 1
Co-sponsored by CVRF |
Moderators: Yun Soo
Bae, Issei Komuro |
Panelists:
Ki Hoon Han, Gou Young Koh |
6:30 PM |
Dinner Reception & Welcome Address |
|
7:00 PM |
Angiogenesis: Role of Angiopoietin-Tie2
System in Vascular Remodeling |
Gou Young Koh |
7:20 PM |
Angiogenesis and Cardiomyocytes Regulation
and Regeneration  |
Issei Komuro |
7:40 PM |
Inflammatory Stress: C-Reactive Protein:
Friend, or Foe?  |
Ki Hoon Han |
8:00 PM |
Oxidative Stress: Novel Function of
NADPH Oxidase in Atherogenesis  |
Yun Soo Bae |
8:20 PM |
Discussion |
|
8:50 PM |
Adjourn |
|
|
|
|
#6. Structural
Heart Disease Symposium
Endovascular Arena, Level 1
Co-sponsored by AGA Corporation |
Moderators: I-Seok Kang,
Horst Sievert |
Panelists:
Mazeni Alwi, Ramesh Arora, Jae-Young Choi, Hong Gu, Soo-Jin
Kim, Lan Hieu Nguyen |
6:00 PM |
Dinner |
|
7:00 PM |
Balloon Assisted Technique in ASD
Closure |
Bharat Dalvi |
7:15 PM |
Catheter Closure of ASD in Elder Patients  |
Teiji Akagi |
7:30 PM |
Intermediate Term and Long Term Outcome
Following Device Closure of ASD  |
Masood Sadiq |
7:45 PM |
Device Closure of Ventricular Septal
Defects: Indications and Technical Considerations |
Ziyad M. Hijazi |
8:00 PM |
Catheter Closure of PMVSD Using Amplatzer
Ductal Occluder  |
Lan Hieu Nguyen |
8:15 PM |
Hemodynamic Assessment Prior to Closure
of Defects in Patients with Pulmonary Hypertension  |
R. Krishna Kumar |
8:30 PM |
Manipulation of the Ductus Arteriosus
in the Treatment of Congenital Heart Disease |
Adolphus Kai-tung Chau |
8:45 PM |
Discussion |
|
9:00 PM |
Adjourn |
|
|
|
|
#7. Global
Cardiovascular Intervention Symposium (CTO: From Coronary
to Peripheral)
Room 2-1(Presidio 1 & 2), Level 2
Co-sponsored by Johnson & Johnson K. K. (Cordis Japan) |
Part 1: Coronary
session
6:30 PM-7:30 PM CTO Treatment - Tips and Tricks (Tentative) |
Part 2: Endovascular
Session
7:30 PM-8:30 PM How Do You Manage Lower Extremity CTO
(Tentative)
* Only for Invited Participants |
|
|
|
|
|
|
|
|